Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
XS106 |
Mouse dentritic cell line | Mouse | immune system | cell line | adherent | plasmid | Metafectene | publication | M. Ohtani et al., Cell. Microbiology, 2012, 14(1): 40–57, doi:10.1111/j.1462-5822.2011.01695.x | Link | |||
U266B1 |
Human multiple myeloma B lymphocyte cell line from peripheral blood | ATCC TIB-196 | Human | immune system | cell line | suspension | plasmid | Metafectene EASY | publication | S. Liberati, PhD Thesis, 2014, Sapienza Universita di Roma | Link | ||
U266B1 |
Human multiple myeloma B lymphocyte cell line from peripheral blood | ATCC TIB-196 | Human | immune system | cell line | suspension | plasmid | Metafectene EASY | publication | M. B. Morelli et al., Int. J. Cancer, 2014, 134:2534-2546, DOI:10.1002/ijc.28591 | Link | ||
THP-1 |
Human monocytic carcinoma cell line | ATCC TIB 202 | Human | immune system | cell line | suspension | plasmid | Metafectene | publication | N. Mukhamedova et al., J. Lipid Res., Nov 2008; 49: 2312 - 2322 | Link | ||
THP-1 |
Human monocytic carcinoma cell line | ATCC TIB 202 | Human | immune system | cell line | suspension | plasmid | RNA-Interference | Metafectene | publication | M.-H. Chien et al., Carcinogenesis, Dec 2009; 30: 2005 - 2013 | ||
RPMI |
Human myeloma B lymphocyte cell line from peripheral blood | Human | immune system | cell line | suspension | plasmid | Metafectene EASY | publication | S. Liberati, PhD Thesis, 2014, Sapienza Universita di Roma | Link | |||
RPMI |
Human myeloma B lymphocyte cell line from peripheral blood | Human | immune system | cell line | suspension | plasmid | Metafectene EASY | publication | M. B. Morelli et al., Int. J. Cancer, 2014, 134:2534-2546, DOI:10.1002/ijc.28591 | Link | |||
PBMC |
Peripheral blood monocyte-derived macrophages | immune system | unknown | plasmid | K2 Transfection System | publication | A. Garg et al., Blood Cells, Molecules, and Diseases, 2016, 59:108-112, doi.org/10.1016/j.bcmd.2016.04.013 | ||||||
mBMDM |
Mouse bone marrow derived macrophages | Mouse | immune system | primary cell | plasmid | K2 Transfection System | publication | C. A. Nold-Petry et al., Nature Immunology, 2015, 16 (4): 354, doi:10.1038/ni.310 | |||||
L1.2-CXCR2 |
Murine pre-B cells, stably expressing the CXCR2 receptor | Murine | immune system | unknown | suspension | plasmid | Metafectene | publication | H. C. Lane et al., Int. Immunol., Aug 2006; 18: 1315 - 1325 | Link | |||
L1.2-CXCR1 |
Murine pre-B cells, stably expressing the CXCR1 receptor | Murine | immune system | unknown | suspension | plasmid | Metafectene | publication | H. C. Lane et al., Int. Immunol., Aug 2006; 18: 1315 - 1325 | Link | |||
K562 |
Human myelogenous leukemia cell line | ATCC CCL-243 | Human | immune system | cell line | suspension | plasmid | Metafectene | publication | O. N. Kuvardina et al., Oncotarget, 2017, 8 (42): 71685-71698 | Link | ||
K562 |
Human myelogenous leukemia cell line | ATCC CCL-243 | Human | immune system | cell line | suspension | plasmid | Metafectene PRO | publication | N. Courtial et al., PLoS ONE, 2013, 8(9): e76637. doi:10.1371/journal.pone.0076637 | Link | ||
K562 |
Human myelogenous leukemia cell line | ATCC CCL-243 | Human | immune system | cell line | suspension | plasmid | Metafectene | publication | C. Rosner et al., J. Immunol., Feb 2011; 186: 2156 - 2163 | Link | ||
K562 |
Human myelogenous leukemia cell line | ATCC CCL-243 | Human | immune system | cell line | suspension | plasmid | Metafectene | publication | A. Meyer, Dissertation, 2020, Universität Stuttgart | Link | ||
K562 |
Human myelogenous leukemia cell line | ATCC CCL-243 | Human | immune system | cell line | suspension | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | O. N. Kuvardina et al., Oncotarget, 2017, 8 (42): 71685-71698 | Link | |
K562 |
Human myelogenous leukemia cell line | ATCC CCL-243 | Human | immune system | cell line | suspension | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | N. Sahner, Dissertation, 2019, Technische Universität Darmstadt | Link | |
K562 |
Human myelogenous leukemia cell line | ATCC CCL-243 | Human | immune system | cell line | suspension | plasmid | Metafectene | publication | O. N. Kuvardina et al., Blood, Jun 2015; 125: 3570 - 3579 | |||
K562 |
Human myelogenous leukemia cell line | ATCC CCL-243 | Human | immune system | cell line | suspension | plasmid | Metafectene | publication | E. Kowenz-Leutz et al., EMBO J., Mar 2010; 29: 1105 - 1115 | Link | ||
Jurkat |
Human leukemia T-cell line | ECACC 88042803 | Human | immune system | cell line | suspension | plasmid | Metafectene PRO | publication | V. Witte et al., J. Immunol., Dec 2008; 181: 8425 - 8432 | Link | ||
Jurkat |
Human leukemia T-cell line | ECACC 88042803 | Human | immune system | cell line | suspension | plasmid | Metafectene PRO | publication | A. K. V. Iyer et al., J. Immunol., 2011, 187(6): 3256–3266, doi:10.4049/jimmunol.1002915. | Link | ||
Jurkat |
Human leukemia T-cell line | ECACC 88042803 | Human | immune system | cell line | suspension | plasmid | Metafectene | publication | Q. Chen et al., J. Biol. Chem., Jul 2006; 281: 19985 - 19994 | Link | ||
Jurkat |
Human leukemia T-cell line | ECACC 88042803 | Human | immune system | cell line | suspension | plasmid | cotransfection (plasmid/plasmid) | K2 Transfection System | publication | K. Marek-Bukowiec et al., Genes and Immunity, 2016, 17: 313-320, doi:10.1038/gene.2016.25 | Link | |
Jurkat |
Human leukemia T-cell line | ECACC 88042803 | Human | immune system | cell line | suspension | plasmid | Metafectene PRO | publication | A. K. V. Iyer et al., J. Immunol., Sep 2011; 187: 3256 - 3266 | Link | ||
Jurkat |
Human leukemia T-cell line | ECACC 88042803 | Human | immune system | cell line | suspension | plasmid | Metafectene PRO | publication | C. Maucksch et al., Nucleic Acids Res., Oct 2008; 36: 5462 - 5471 | Link |